Ophthalmic Disorders Resource Center

Click on the subcategory below to find drug monographs for that particular area.

Dry Eyes: Updates on Diagnosis, Treatment

As dry eyes is one of the most common reasons for patient visits to eye care professionals, the latest issue of the journal Optometry and Vision Science focuses on progress in the risk factors, diagnosis, and treatment of dry eye disease.

USPSTF Revisits Eye Screening for Seniors

The USPSTF has concluded that there is currently insufficient evidence to assess the benefits and harms of screening for impaired visual acuity in older adults.

Smart' intelli-Case Cleared by FDA

The FDA has cleared the intelli-Case for use with hydrogen peroxide solutions.

Eye Bacteria Changes With Contact Lenses

Changes in bacteria populations may be one reason why people who wear contact lenses are more prone to eye infections, a new study suggests.

Ophthalmic NSAIDs for Common Indications Compared

A recent review compared published data on the efficacy of several ophthalmic nonsteroidal anti-inflammatory drugs (NSAIDs), within and outside their FDA-approved uses.

Seizure Drug Boosts MS Patient Eyesight

New research suggests that a medication indicated to treat seizures could also reduce the risk of nerve damage and blindness in patients with multiple sclerosis (MS).

Ocular Syphilis: What Clinicians Should Know

The Centers for Disease Control and Prevention (CDC) has issued a clinical advisory on ocular syphilis due to recent confirmed and suspected cases in several states.

Eye Complications Possible with Measles

In the midst of the current resurgence of measles across the United States, ophthalmologists are warning that even before the telltale skin rash appears, the infection typically shows up in the eyes.


Significant Disparities in Care for Pediatric Retinoblastoma

Significant disparities in care and outcomes exist for children with retinoblastoma, according to a study published in JAMA Pediatrics.

Dextenza NDA for Ocular Pain Submitted to the FDA

The New Drug Application (NDA) for Dextenza (sustained release dexamethasone; Ocular Therapeutix) 0.4mg Intracanalicular Depot has been submitted to the FDA for the treatment of ocular pain following ophthalmic surgery.

Retinal Ganglion Cell Count Could ID Normal-Tension Glaucoma

Weighted retinal ganglion cell (RGC) count has higher potential than other parameters for differentiating normal eyes from those with glaucoma.

Clinical Charts

Make prescribing decisions with our charts and treatment algorithms.

Featured courses from mycme

Cannabinoid Offers Modest Relief From Pain, SpasticityExternal web site

Among the many issues clinicians face today, staying current with advances in medicine is becoming ...

CME|CE 0.25 Credits

PANCE/PANRE Review: Pulmonology, Pediatrics, Ophthalmology, & OtorhinolaryngolyExternal web site

This module reviews all topics on the NCCPA examination blueprint relating to Pulmonology, Ophthalmology, and ...

CME 4.50 Credits

Vitreomacular Traction, Macular Hole Treatment, and Injection TechniqueExternal web site

This webcast will discuss the pathophysiology and diagnostic criteria of VMA/VMT and treatment options for ...

CME 1.50 Credits

Sign Up for Free e-newsletters